tiprankstipranks
ImmunoCellular Therapeutics (IMUC)
OTHER OTC:IMUC
US Market

ImmunoCellular Therapeutics (IMUC) Balance Sheet

Compare
180 Followers

ImmunoCellular Therapeutics Balance Sheet

ImmunoCellular Therapeutics's total assets for Q3 2023 were $0.00, a decrease of ― from the previous quarter. IMUC total liabilities were $0.00 for the fiscal quarter, a ― a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20
Total Assets
$ 409.42K$ 768.80K$ 1.67M$ 266.70K
Total Liabilities
$ 6.10M$ 4.96M$ 1.84M$ 137.13K
Total Equity Gross Minority
$ -5.69M$ -4.19M$ -171.52K$ 129.58K
Other Metrics
$ ―$ ―$ ―$ ―
Currency in USD

ImmunoCellular Therapeutics Debt to Assets

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis